Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. 1999

T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.

Our hypothesis is that oxytocin (OT) causes natriuresis by activation of renal NO synthase that releases NO followed by cGMP that mediates the natriuresis. To test this hypothesis, an inhibitor of NO synthase, L-nitroarginine methyl ester (NAME), was injected into male rats. Blockade of NO release by NAME had no effect on natriuresis induced by atrial natriuretic peptide (ANP). This natriuresis presumably is caused by cGMP because ANP also activates guanylyl cyclase, which synthesizes cGMP from GTP. The 18-fold increase in sodium (Na+) excretion induced by OT (1 microgram) was accompanied by an increase in urinary cGMP and preceded by 20 min a 20-fold increase in NO3- excretion. NAME almost completely inhibited OT-induced natriuresis and increased NO3- excretion; however, when the dose of OT was increased 10-fold, a dose that markedly increases plasma ANP concentrations, NAME only partly inhibited the natriuresis. We conclude that the natriuretic action of OT is caused by a dual action: generation of NO leading to increased cGMP and at higher doses release of ANP that also releases cGMP. OT-induced natriuresis is caused mainly by decreased tubular Na+ reabsorption mediated by cGMP. In contrast to ANP that releases cGMP in the renal vessels and the tubules, OT acts on its receptors on NOergic cells demonstrated in the macula densa and proximal tubules to release cGMP that closes Na+ channels. Both ANP- and OT-induced kaliuresis also appear to be mediated by cGMP. We conclude that cGMP mediates natriuresis and kaliuresis induced by both ANP and OT.

UI MeSH Term Description Entries
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D004573 Electrolytes Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed) Electrolyte
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic

Related Publications

T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
August 1995, Proceedings of the National Academy of Sciences of the United States of America,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
October 1992, Kidney international,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
December 1993, Neuroendocrinology,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
January 1991, Contributions to nephrology,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
December 1993, Neuroendocrinology,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
January 1991, Biochemical and biophysical research communications,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
June 1985, Canadian journal of physiology and pharmacology,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
July 1986, Proceedings of the National Academy of Sciences of the United States of America,
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
September 1986, Clinical science (London, England : 1979),
T J Soares, and T M Coimbra, and A R Martins, and A G Pereira, and E C Carnio, and L G Branco, and W I Albuquerque-Araujo, and G de Nucci, and A L Favaretto, and J Gutkowska, and S M McCann, and J Antunes-Rodrigues
January 1991, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!